SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-060342
Filing Date
2020-05-13
Accepted
2020-05-12 21:57:59
Documents
17
Period of Report
2020-06-25
Effectiveness Date
2020-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2019396d1_def14a.htm DEF 14A 1085430
2 GRAPHIC image_001.jpg GRAPHIC 7582
3 GRAPHIC image_002.jpg GRAPHIC 3422
4 GRAPHIC image_003.jpg GRAPHIC 2388
5 GRAPHIC image_004.jpg GRAPHIC 2376
6 GRAPHIC image_005.jpg GRAPHIC 2839
7 GRAPHIC image_006.jpg GRAPHIC 2393
8 GRAPHIC image_007.jpg GRAPHIC 3084
9 GRAPHIC image_008.jpg GRAPHIC 3209
10 GRAPHIC image_009.jpg GRAPHIC 2491
11 GRAPHIC image_010.jpg GRAPHIC 2458
12 GRAPHIC image_011.jpg GRAPHIC 2388
13 GRAPHIC image_012.jpg GRAPHIC 17169
14 GRAPHIC proxycard_1.jpg GRAPHIC 116841
15 GRAPHIC proxycard_2.jpg GRAPHIC 167692
16 GRAPHIC regno_001.jpg GRAPHIC 516820
17 GRAPHIC regno_002.jpg GRAPHIC 475924
  Complete submission text file 0001104659-20-060342.txt   2919111
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 20870901
SIC: 2836 Biological Products, (No Diagnostic Substances)